Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we inform you that w.e.f. 18-October-2025, Dr. Umesh Luthra has resigned as Independent Director and Dr. Vijay Ojha has been appointed as an additional director and Independent Director of the Company. Annexures containing details as prescribed vide SEBI circular dated July 13, 2013 are enclosed. A copy of the letter received from Dr. Umesh Luthra for his resignation is enclosed.
Announcement under Regulation 30 (LODR)-Change in Directorate
Filed with BSE · · 4 pages · English
Release
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Financial Results For The Quarter And Half Year Ended 30-Sep-2025
- Sudarshan Pharma Industries Ltd Press Release Oct 15 2025
- Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended 30-Sep-2025
- Sudarshan Pharma Industries Ltd Press Release Sep 30 2025
- Closure of Trading Window
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Sudarshan Pharma Industries Ltd Press Release Oct 20 2025
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Sudarshan Pharma Industries Ltd Press Release Dec 11 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries